bone disorder therapy (Zeneca)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebone disorder therapy (Zeneca)
Drug Alias Nameacetyl-leu-leu-norleucinol
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin L inhibitors
TargetsCathepsin L
Therapy Area/IndicationsOsteoarthritisArthritis, RheumatoidOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZeneca Group Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsOsteoarthritisArthritis, RheumatoidOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A